216
Participants
Start Date
April 1, 2015
Primary Completion Date
April 27, 2016
Study Completion Date
May 25, 2016
Epoetin alfa
Administered intravenously (IV) three times a week (TIW) by appropriately trained healthcare professionals during hemodialysis.
Research Site, The Bronx
Research Site, Astoria
Research Site, Brooklyn
Research Site, Rosedale
Research Site, Meadville
Research Site, Philadelphia
Research Site, Norfolk
Research Site, Hampton
Research Site, Carrboro
Research Site, Wilmington
Research Site, Statesboro
Research Site, Macon
Research Site, Pembroke Pines
Research Site, Miami
Research Site, Miami Gardens
Research Site, Michigan City
Research Site, Merrillville
Research Site, Roseville
Research Site, Detroit
Research Site, Pontiac
Research Site, Kansas City
Research Site, Lincoln
Research Site, Houston
Research Site, Houston
Research Site, San Antonio
Research Site, Los Angeles
Research Site, Los Angeles
Research Site, Whittier
Research Site, Montebello
Research Site, Cerritos
Research Site, Glendale
Research Site, San Diego
Research Site, Riverside
Research Site, Simi Valley
Research Site, Vacaville
Research Site, Burlington
Research Site, Toa Baja
Lead Sponsor
Amgen
INDUSTRY